Lion Point Capital »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Lion Point Capital

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.0M 105k 18.67

More positions owned by Lion Point Capital

Ishares Tr Russell 2000 Etf Put Option (IWM)
Ardelyx (ARDX)
Insmed Com Par $.01 (INSM)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Milestone Pharmaceuticals (MIST)
Geron Corporation (GERN)
Marinus Pharmaceuticals Com New (MRNS)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Mirum Pharmaceuticals Put Option (MIRM)
Syndax Pharmaceuticals (SNDX)
Bridgebio Pharma (BBIO)
Avadel Pharmaceuticals Com Shs (AVDL)
Neurocrine Biosciences (NBIX)
Fennec Pharmaceuticals (FENC)
Mineralys Therapeutics (MLYS)

View all positions for Lion Point Capital

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

BlackRock
BlackRock
Fairmount Funds Management
Braidwell
Baker Bros. Advisors
Rubric Capital Management
Morgan Stanley
Hillhouse Capital Advisors
State Street Corporation
Pictet Asset Management Holding SA
Nuveen Asset Management
Dimensional Fund Advisors
Driehaus Capital Management
Rice Hall James & Associates
Parkman Healthcare Partners

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A